首页 > >
EDG勇夺S11全球总冠军 OPPO送100台Find X3！******OPPO做为英雄联盟全球总决赛及英雄联盟职业赛官方网合作方，全程呐喊助威中国战队，并在复赛前立过Flag：LPL夺冠就套弄100台OPPO Find X3手机上，现如今这一理想早已成为了实际！�PChome手机频道栏目新闻报导】在今天零晨完毕的英雄联盟S11全球总决赛上，来源于LPL中国分赛区的战队EDG取得成功战胜卫冕冠军世界大赛DK，赢下了2021全球总决赛总冠军！OPPO做为英雄联盟全球总决赛及英雄联盟职业赛官方网合作方，全程呐喊助威中国战队，并在复赛前立过Flag：LPL夺冠就套弄100台OPPO Find X3手机上，现如今这一理想早已成为了实际！
做为英雄联盟全球总决赛的官方网合作方，OPPO从决赛一开始就全程参加，在每一次中国战队得到优异成绩的过程中都给油呐喊助威。与此同时在EDG进到总决赛后，也是公布一个小号Flag，称LPL夺冠就套弄100台OPPO Find X3手机上。
实际上OPPO与英雄联盟早已协作很多年，而且仍在持续深入协作。除开电脑上端英雄联盟外，OPPO Reno6 Pro 还变成了2021—2023年度中国英雄联盟手游游戏比赛特定用机。由此可见OPPO针对全民游戏及其重磅消息比赛是共同关注的，这与OPPO手机上普遍的客户群体十分切合。
Chinese thriller "Sheep Without a Shepherd 2" tops domestic box office******
BEIJING, Dec. 18 (Xinhua) -- Domestic thriller film "Sheep Without a Shepherd 2" topped the Chinese mainland box office chart on its debut on Friday, data from the China Movie Data Information Network showed Saturday.。
The movie, which is a sequel to "Sheep Without a Shepherd" released in 2019, depicts the story of a poor family and a desperate father who gives all his efforts to collect money for his son's operation. It earned 92.7 million yuan (around 14.6 million U.S. dollars) on Friday.。
Domestic animation "I am Who I am," which also premiered on Friday, ranked second on the box office chart, raking in about 7.8 million yuan on its release day. The movie tells the stories of three kids realizing their dream of lion dancing through arduous practice.。
It was followed by domestic adventure "Schemes In Antiques," which pocketed about 6 million yuan. Enditem。
US authorizes 'mix******
The US Food and Drug Administration on Wednesday authorized using a so-called "mix-and-match" strategy for people who require a booster shot of a COVID-19 vaccine after their primary series.
"The FDA has determined that the known and potential benefits of the use of a single heterologous booster dose outweigh the known and potential risks of their use in eligible populations," the agency said in a statement.
The Pfizer, Moderna and Johnson & Johnson vaccines are authorized in the United States. A single dose of any of them may now be used following completion of primary vaccination with a different COVID-19 vaccine.
According to the new decision, people who received two Moderna shots initially and are 65 or older, over 18 and at high risk for COVID-19, or over 18 and have high occupational exposure, may now receive a booster.
All adults who received the one-shot J&J vaccine more than two months ago are also eligible for a booster.
Previously, only immune compromised people or people who belonged to elderly or high-risk groups and had received the Pfizer vaccine initially were eligible for a boost.
The data supporting the decisions come from emerging research reviewed by the FDA.
"Today's actions demonstrate our commitment to public health in proactively fighting against the COVID-19 pandemic," said acting FDA commissioner Janet Woodcock.
The statement also cautioned of highly rare side effects associated with the vaccines.
The messenger RNA vaccines, Pfizer and Moderna, have been associated with increased risks of inflammatory heart conditions, myocarditis and pericarditis, especially in younger males.
The J&J vaccine has been linked to a serious and rare type of blood clot in combination with low blood platelets one or two weeks after administration. The risk is highest among females ages 18 through 49 years.